Zika virus remains a threat to public health due to its close association with microcephaly and other severe birth defects.
Dr. Patricia Shi and colleagues first to initiate study in sickle cell patients of an alternative mobilizing agent, plerixafor.
MERS-CoV, a newly emerging, highly pathogenic infectious virus, continues to threat public health worldwide with high mortality rate (about 35%).
We offer a comprehensive menu of services and products to support and manage the full spectrum of transfusion medicine, regenerative medicine and cellular-therapy related research projects, from basic science to full scale clinical trials.
New York Blood Center (NYBC) is one of the largest independent, community-based, nonprofit blood centers in the United States.